Searchable abstracts of presentations at key conferences in endocrinology

ea0056p829 | Pituitary - Clinical | ECE2018

Cancer in acromegaly: a case-control study

Gil Susana Mallea , Stalldecker Graciela , Diez Sabrina , Palazzo Adriana , Peressotti Bruno , Ballarino Carolina

Carcinomas are the third most frequent cause of complications in acromegalic patients. It has been suggested that diabetes potentiates the risk of cancer. To assess the frequency and type of malignant neoplasms in acromegalic patients and control group; to evaluate, in both groups, the relationship between IGF-I/GH and the development of cancer, and between glucose metabolism and cancer in two centers of Buenos Aires, Argentina. Retrospective, cross-sectional study; medical re...

ea0073aep470 | Pituitary and Neuroendocrinology | ECE2021

Nonfunctioning pituitary adenomas: What can we do? What we did

Mallea-Gil Susana , Cuccia Mariela , Tubert Gloria , Diez Sabrina , Ballarino Carolina

Nonfunctioning pituitary adenomas (NFAs) have no symptoms of hormonal overproduction and can be asymptomatic or have severe symptoms due to mass effects. The aim of our study was to assess clinical features and therapeutic outcomes in patients with clinically NFAs. We retrospectively collected data of 175 patients from 3 hospitals of Buenos Aires. Mean age: 51 years (r:13–90), 52% women, mean follow-up: 7.37 years. At diagnosis, clinical presentation was: visual field def...

ea0070aep672 | Pituitary and Neuroendocrinology | ECE2020

Giant prolactinomas: Is it possible to stop treatment?

Mallea-Gil Susana , Diez Sabrina , Tubert Gloria , Cuccia Mariela , Rodriguez Noelia , Stalldecker Graciela , de los Angeles Sosa Maria , Peressotti Bruno , Palazzo Adriana , Ballarino Carolina

Giant prolactinomas are tumors with a large size >4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists (DA), mainly cabergoline (CAB), are the first-line choice in the treatment of these tumorsTo assess the efficacy, safety and long-term follow-up of patients with giant prolactinomas treated with DA. We retrospectively reviewed the clinical records of 33 patients with giant prolactinomas. Mea...

ea0090ep799 | Pituitary and Neuroendocrinology | ECE2023

Craniopharyngiomas in adult patients: Retrospective, multicentric study in Buenos Aires, Argentina

Mallea-Gil Susana , Glerean Mariela , Rogozinski Amelia , Ballarino Carolina , Battistone Maria Florencia , Danilowicz Karina , Diez Sabrina , Day Patricia Fainstein , Furioso Alejandra , Guitelman Mirtha , Katz Debora , Loto Monica , Martinez Marcela , Miragaya Karina , Sosa Soledad , Slavinsky Patricia , Tkatch Julieta , Vitale Marcelo , Pernas Valeria Gonzalez , Roel Valeria Garcia , Pingel Jesica

Craniopharyngiomas are rare lesions derived from cell remnants of Rathke’s pouch, usually localized in the sellar and suprasellar areas.Objectives: To analyze clinical, endocrine and histological features in a group of patients from Buenos Aires city. To assess efficacy, number of surgeries and complications after surgery or other treatments.Material and methods: Multicentric, retrospective, transversal study. Adult patients w...